United States Bioinformatics Market to Grow with Impressive CAGR until 2027
United States Bioinformatics Market
is anticipated to grow with growing investments in the healthcare industry, in
the forecast period, 2023-2027F.
According to TechSci Research report on, “United
States Bioinformatics
Market - By Region, Competition
Forecast & Opportunities, 2027”,
United States bioinformatics market might register an impressive CAGR during
the forecast period, 2023-2027, to establish growth due to technological
advancement in the biotechnology sector of the healthcare industry. Biotechnology
& genetics holds a vast arena for the advancement and evolution that can
help in the advancement of medicine and therapeutic processes. Identification
of the unknown species, identifying the microorganisms, the protein
translations, DNA & RNA analysis, genomic studies, pharmacogenomics, are
various sectors that revolves on the advancements of bioinformatics.
Bioinformatics in simple terms is defined as the
applications of computing systems, mathematics, physics and biology altogether.
The field includes applications of computer programs that enable efficient
access to, management, and use of, various types of information and development
of the new algorithms and statistical measures that allows the use of big data
technologies. Gene prediction, protein analysis, protein structure predictions,
etc. are feasible due to bioinformatics. The bioinformatics applies into
pattern recognition, data mining, machine learning algorithms, and
visualization. Further researches include gene expression and protein–protein
interactions, genome-wide association studies, the modeling of evolution and
cell division/mitosis.
Demands for advanced medicine, genomic drugs,
precision medicine aids to the growth of the United States bioinformatics
market in the upcoming five years. Increasing instances of infectious diseases,
new infectious disease spreads, growing instances of rare diseases, and rapid
evolution in the microorganisms that cause severe diseases further supports the
growth of the United States bioinformatics market in the next five years. The
government is actively investing in the research and development of the
technologies and data storage further aids the growth of the United States
bioinformatics market in the future five years.
Browse over XX market
data Figures spread through 70 Pages and an in-depth
TOC on "United States Bioinformatics Market"
https://www.techsciresearch.com/report/united-states-bioinformatics-market/9468.html
The United States bioinformatics market is
segmented by product & services, type, application, end user, competitional
landscape, and regional distribution.
Based on product & services, the market is
further segmented into bioinformatics tools, bioinformatics platforms, and
bioinformatics services. Bioinformatics platforms are anticipated to hold the
largest revenue shares of the market and dominate the market segment in the
upcoming five years on the grounds of rowing demand for data analytics and data
engineering. The growing demand for various sequencing techniques like nanopore
sequencing, DNA & RNA sequencing,
protein sequencing, Next-generation sequencing, etc. further supports the growth of the
sub-segment along with the growth of the United States bioinformatics market in
the next five years.
By type, the market is fragmented into genomics
& proteomics, simulation studies & molecular modelling, genetic
engineering, and others. Simulation studies & molecular modelling is
anticipated to hold the largest revenue shares of the market and dominate the
segment in the upcoming five years on grounds of growing demands from the
biopharmaceuticals companies and increasing demands for the drug development
and discovery. Higher investments, growing research and development of the
therapeutics and pharmaceuticals further aids the growth of the United States
bioinformatics market in the future five years.
Based on application, the market is bifurcated into
metagenomics, drug discovery, precision medicine, and others. Precision
medicine is anticipated to hold the largest revenue shares of the market and dominate
the market segment in the future five years due to growing demands for the
advanced pharmaceuticals with the specific genetic medicines and similar
pharmacological products. By end user, the market is differentiated between
institutional research and industrial research.
A partial list of major market players of the United
States bioinformatics market includes:
·
Illumina, Inc.
·
Thermo Fischer Scientific, Inc.
·
Agilent Technologies, Inc.
·
PerkinElmer Inc.
·
QIAGEN Inc.
·
23AndMe
·
DataTrack International, Inc.
·
Biovia-Dassault Systemes
·
Waters Corporation
·
SOPHiA GENETICS
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=9468
Customers can also request for 10% free customization on this report.
“Institutional research is
the key element that is driving the growth of the large market shares along
with the applications in medical biotechnology. Advancements in the
biotechnology procedures include nanopore sequencing technology, protein sequencing,
Next-generation sequencing, DNA & RNA sequencing, etc. that are
consistently carried out as institutional research. The researches carried out
are usually to discover potential cause of infectious disease, drug discovery,
categorization and analysis of the diseases and disease causing microbes.
Industrial research is often carried out for the drug development procedures.
To find drug delivery system, and advances in other pharmaceutical products.
The research and development segment in the healthcare industry in the United
States is anticipated to grow exponentially with the growing investment and
surging demands for the technological advancement in genome projects. New
market players may invest in the research sector and form merger & acquisitions
for the future market growth,” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“United States
Bioinformatics Market By Product & Services (Bioinformatics Tools,
Bioinformatics Platforms, Bioinformatics Services), By Type (Genomics &
Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering,
Others), By Application (Metagenomics, Drug Discovery, Precision Medicine,
Others), By End User (Institutional Research v/s Industrial Research), By
Region, Competition Forecast & Opportunities, 2027” has evaluated the future
growth potential of United States bioinformatics market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in United States bioinformatics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com